✦ LIBER ✦

Prolonged treatment with pegylated interferon α 2b plus ribavirin improves sustained virological response in chronic hepatitis C genotype 1 patients with late response in a clinical real-life setting in Japan

✍ Scribed by Sumio Watanabe; Nobuyuki Enomoto; Kazuhiko Koike; Namiki Izumi; Hajime Takikawa; Etsuko Hashimoto; Fuminori Moriyasu; Hiromitsu Kumada; Michio Imawari; PERFECT Study Group

Book ID: 118088190
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 233 KB
Volume: 40
Category: Article
ISSN: 1386-6346
DOI: 10.1111/j.1872-034x.2009.00567.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Short duration treatment in genotype 1 c

Short duration treatment in genotype 1 chronic hepatitis C patients with rapid virologic response to pegylated interferon plus ribavirin

✍ Renato Bonardi; Marco Tabone; Aldo Manca; Rinaldo Pellicano; Alessia Ciancio; Ma 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 229 KB

Pegylated interferon alpha-2b plus ribav

Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: The role of rapid and early virologic response

✍ Sanaa M. Kamal; Samer S. El Kamary; Michelle D. Shardell; Mohamed Hashem; Imad N 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB 👁 2 views

In patients chronically infected with hepatitis C virus (HCV) genotype 4, the optimum duration of therapy and the predictors of sustained virologic response (SVR) have not been adequately determined. In this study, 358 patients with chronic hepatitis C genotype 4 were randomly assigned to pegylated

Pegylated interferon alpha-2b (Peg-IFN α

Pegylated interferon alpha-2b (Peg-IFN α-2b) affects early virologic response dose-dependently in patients with chronic hepatitis C genotype 1 during treatment with Peg-IFN α-2b plus ribavirin

✍ T. Oze; N. Hiramatsu; T. Yakushijin; M. Kurokawa; T. Igura; K. Mochizuki; K. Ima 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

Insulin resistance is a major determinan

Insulin resistance is a major determinant of sustained virological response in genotype 1 chronic hepatitis C patients receiving peginterferon α-2b plus ribavirin

✍ C.-J. CHU; S.-D. LEE; T.-H. HUNG; H.-C. LIN; S.-J. HWANG; F.-Y. LEE; R.-H. LU; M 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

Mutations in the interferon sensitivity

Mutations in the interferon sensitivity determining region and virological response to combination therapy with pegylated-interferon alpha 2b plus ribavirin in patients with chronic hepatitis C-1b infection

✍ Mina Nakagawa; Naoya Sakamoto; Mayumi Ueyama; Kaoru Mogushi; Satoshi Nagaie; Yas 📂 Article 📅 2010 🏛 Springer Japan 🌐 English ⚖ 266 KB

Analysis of variables and interactions a

Analysis of variables and interactions among variables associated with a sustained virological response to pegylated interferon alfa-2a plus ribavirin in hepatitis C virus genotype 3-infected patients

✍ Hafsa Aziz; Abida Raza; Yasir Waheed; Uzma Gill; Muzaffar Lateef Gill 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 286 KB